
Boston
Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.
Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.
In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.
A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.
Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”
Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.
Paris
Olivier advises French and international clients on all aspects of corporate law. He mainly intervenes in national and international mergers and acquisitions (whether public or private M&A transactions), joint-venture and equity capital market transactions. He focuses in particular in the sectors of industry, financial institution (banks and insurance companies), energy and infrastructures, and real estate investments. He regularly advises French listed companies in connection with the preparation of their draft resolutions, the calling and holding of their shareholders’ meetings and their annual reports / URD.
He is recognized as a “rising star” in M&A in Legal 500 EMEA 2020, and a notable practitioner for M&A, private equity and ECM in IFLR 1000 since 2016.
According to Legal 500 EMEA 2019 & 2020, clients praise Olivier for being “very talented and hands-on” and “a very good professional who is able to manage pressure very well”.
Paris
Martin’s practice focuses on debt financing transactions, including leveraged acquisition financings, for private credit funds, private equity sponsors, corporates and special situations funds.
Prior to joining Orrick, he was an associate at another leading US law firm
New York
Jared’s practice focuses on debt financing of a broad range of domestic and cross-border renewable and conventional power, energy and infrastructure, satellite and telecommunications and transportation projects. He supports scaling into large projects and portfolios and commercializing new technology in clean energy, sustainable infrastructure and space.
Working with private equity sponsors, credit funds and portfolio companies, he has significant experience with a variety of finance structures, including development and construction financings and traditional project finance, subordinated and mezzanine financings, term loan B financings, direct lending, syndicated debt financings, private placements, climate and impact finance, acquisition financings, M&A and restructurings. He has also represented debtors and creditors in restructuring matters.
Jared also maintains an active pro bono practice and assists developing countries in bringing sustainable projects to market. He has worked with representatives of Bangladesh, Chile, Colombia, Egypt, Ethiopia, Fiji, Jamaica, Kenya and Vietnam on high-level sustainable project preparation and structuring matters.
Orange County
San Francisco
San Francisco
These matters involved issues such as government contractor immunity to patent infringement; the effect of amendments to a patent licensing agreement; the effect of an expired utility patent for a chemical composition on the validity of a related trademark for medical implants; the copyrightability of short phrases and the merger doctrine; the copyrightability and fair use of religious materials; and multiple oppositions to office actions, and petitions to cancel trademark registrations to the Trademark Trial & Appeal Board.
Daniel has also worked on Internet-related matters involving the legal effect of “browsewrap” agreements; violations of Web page terms of use; the circumvention of technological barriers to access Web pages; violations of the Computer Fraud and Abuse Act; copyright issues related to cache copying of Web pages; the use of “spiders” to collect data from Web pages; the legality of “deep-linking” to web pages; and the legality of search engine aggregation and display of copyrighted Web pages.
Daniel has recently co-authored a scholarly article with Warrington S. Parker III entitled, "The Differing Approaches to Preemption Under the Uniform Trade Secrets Act" that was published in Volume 49, Issue 2 of the Tort Trial & Insurance Practice Law Journal. Daniel is also a contributing author to the NorCal IP Blog, which covers notable new intellectual property case filings and verdicts in the Northern District of California. Links to articles Daniel has authored can be found under the "Publications" section of this bio.